Category Press Releases

Kivu

IBL International Partners with Grifols to Develop Cutting-Edge Biomarker Panels

IBL International Partners with Grifols to Develop Cutting-Edge Biomarker Panels IBL International GmbH, a Tecan Group company renowned for its expertise in specialty diagnostics, has officially announced a strategic partnership with Grifols, a global healthcare leader with a legacy in…

Read MoreIBL International Partners with Grifols to Develop Cutting-Edge Biomarker Panels
Alpenglow

Alpenglow Biosciences to Host AACR 2025 Dinner Talk on Spatial Biology in Endometrial Cancer

Alpenglow Biosciences to Host AACR 2025 Dinner Talk on Spatial Biology in Endometrial Cancer Alpenglow Biosciences, a leading innovator in 3D spatial biology and digital pathology, is pleased to announce its exclusive Dinner Lecture during the American Association for Cancer…

Read MoreAlpenglow Biosciences to Host AACR 2025 Dinner Talk on Spatial Biology in Endometrial Cancer
Sail Biomedicines

Sail Biomedicines Welcomes Dr. Laura Sepp-Lorenzino to Its Board of Directors

Sail Biomedicines Welcomes Dr. Laura Sepp-Lorenzino to Its Board of Directors Sail Biomedicines, Inc., a pioneering biotechnology company at the forefront of programmable RNA-based medicines and a Flagship Pioneering-founded enterprise, today announced the appointment of Laura Sepp-Lorenzino, Ph.D., to its…

Read MoreSail Biomedicines Welcomes Dr. Laura Sepp-Lorenzino to Its Board of Directors
Biosciences

Perth Biosciences Collaborates with Japan’s Scrum Corporation for Distribution

Perth Biosciences Collaborates with Japan’s Scrum Corporation for Distribution Perth Biosciences, a pioneering leader in the accessibility and scalability of single-cell sequencing, has officially announced a strategic agreement with Tokyo-based Scrum Inc., a premier distributor of life sciences and biotechnology…

Read MorePerth Biosciences Collaborates with Japan’s Scrum Corporation for Distribution
BioMedicines

Endeavor BioMedicines Welcomes ILD Expert Dr. Lisa Lancaster as Chief Medical Officer

Endeavor BioMedicines Welcomes ILD Expert Dr. Lisa Lancaster as Chief Medical Officer Endeavor BioMedicines, a clinical-stage biotechnology company dedicated to developing groundbreaking treatments for life-threatening diseases, has announced the appointment of Lisa Lancaster, M.D., as its new Chief Medical Officer.…

Read MoreEndeavor BioMedicines Welcomes ILD Expert Dr. Lisa Lancaster as Chief Medical Officer